Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,620 | N/A | -17,530 | N/A | 2,450 |
| Depreciation Amortization | 1,930 | N/A | 860 | N/A | 1,820 |
| Other Working Capital | -1,540 | N/A | -11,170 | N/A | 62,150 |
| Other Operating Activity | 25,820 | 0 | 8,610 | 0 | -10,980 |
| Operating Cash Flow | $3,590 | $N/A | $-19,230 | $N/A | $55,440 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,200 | N/A | -3,410 | N/A | -410 |
| Net Acquisitions | -3,160 | N/A | -3,150 | N/A | 670 |
| Other Investing Activity | -370 | 0 | -110 | 0 | -2,050 |
| Investing Cash Flow | $-7,730 | $N/A | $-6,670 | $N/A | $-1,790 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 220,740 | 0 | 216,090 | 0 | 76,940 |
| Financing Cash Flow | $220,740 | $N/A | $216,090 | $N/A | $76,940 |
| Exchange Rate Effect | 7,570 | N/A | -420 | N/A | 8,650 |
| Beginning Cash Position | 124,750 | N/A | 124,270 | N/A | 10,040 |
| End Cash Position | 348,920 | N/A | 314,040 | N/A | 149,280 |
| Net Cash Flow | $224,170 | $N/A | $189,760 | $N/A | $139,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,590 | N/A | -19,230 | N/A | 55,440 |
| Free Cash Flow | 3,590 | 0 | -19,230 | 0 | 55,440 |